Suchergebnisse - "Kelly, Peter J"

PubPharm (358)

61

Communication of health risk in substance-dependent populations : A systematic review of randomised controlled trials

enthalten in: Drug and alcohol review | 2021

von Goh, M. | Kelly, P. | Deane, F. | +2

62

N-acetylcysteine (NAC) for methamphetamine dependence : A randomised controlled trial

enthalten in: EClinicalMedicine | 2021

von McKetin, R. | Dean, O. | Turner, A. | +23

63

Inflammation and Stroke Risk : A New Target for Prevention

enthalten in: Stroke | 2021

von Kelly, P. | Lemmens, R. | Tsivgoulis, G.

64

Patterns and predictors of nicotine replacement therapy use among alcohol and other drug clients enrolled in a smoking cessation randomised controlled trial

enthalten in: Addictive behaviors | 2021

von Guillaumier, A. | Skelton, E. | Tzelepis, F. | +6

65

The use of Australian SMART Recovery groups by people who use methamphetamine : Analysis of routinely-collected nationwide data

enthalten in: Drug and alcohol dependence | 2021

von Beck, A. | Larance, B. | Deane, F. | +6

66

Inflammation, Cholesterol, and Stroke Risk : Building Evidence for a Dual Target Strategy for Secondary Prevention

enthalten in: Stroke | 2021

von McCabe, J. | Kelly, P.

CommentOn: Stroke. 2021 Aug;52(9):2827-2836. - PMID 34281380

67

Predictors of consent and engagement to participate in telephone delivered continuing care following specialist residential alcohol and other drug treatment

enthalten in: Addictive behaviors | 2021

von Kelly, P. | Ingram, I. | Deane, F. | +9

68

Facilitators and barriers to integrating physical health care during treatment for substance use : A socio-ecological analysis

enthalten in: Drug and alcohol review | 2021

von Osborne, B. | Kelly, P. | Robinson, L. | +3

69

Routine outcome measurement in specialist non-government alcohol and other drug treatment services : Establishing effectiveness indicators for the NADAbase

enthalten in: Drug and alcohol review | 2021

von Kelly, P. | Deane, F. | Davis, E. | +5

70

Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack : a pooled analysis of individual patient data from cohort studies

enthalten in: The Lancet. Neurology | 2021

von Best, J. | Ambler, G. | Wilson, D. | +99

CommentIn: Lancet Neurol. 2021 Apr;20(4):252-254. - PMID 33743229